Healthcare news, Nov 9 to 15, 2026
The 15 healthcare stories that mattered most to marketing teams so far this week, picked from 12 outlets and ranked by impact. Each one says why it matters and links to the original reporting.
The week in healthcare
LivingPHOENIX obtains China’s first medical device registration for biomimetic collagen
Marketing teams in medical‑device and biotech firms can now reference a regulatory precedent when positioning similar collagen‑based products for China, accelerating market entry plans. They should begin tailoring compliance‑focused messaging and local market campaigns to leverage this breakthrough.
vietnamtribune.com · also thehindubusinessline.com, malaysiasun.com, australiannews.net
AWS pledges $100 million in AI and cloud credits for health groups in underserved areas
Marketing teams in the health sector can align their messaging with AWS’s equity push, showcasing partnerships that improve access to care. Highlighting the initiative in content can attract donors, partners, and talent who value technology‑enabled health solutions.
SiliconANGLE · also Healthcare Dive
NorthShore Care Supply announces winners of 2026 Healthcare Marketing Impact Awards
Marketers can study the award‑winning campaigns to identify tactics that generate strong ROI in health‑care. Incorporating similar approaches could improve audience engagement and conversion rates for their own initiatives.
Ad Age · also Modern Healthcare
FDA Approves First Factor Xla Inhibitor to Help Prevent Stroke in Certain Adults at High Risk
Rules like this change what marketing can claim, collect or run. Worth a check with legal and a plain-English explainer for customers.
FDA
Novartis tells men to ‘Relax Your Tight End’ for prostate cancer screening
A move in your market that customers and prospects will hear about. Worth checking against your positioning before someone asks.
Ad Age
Voices of Alzheimer’s animated short film framed early cognitive screening as an extension of care
A move in your market that customers and prospects will hear about. Worth checking against your positioning before someone asks.
Ad Age
STAT+: Dutch antitrust regulators probe Biogen over test for its MS drug
Rules like this change what marketing can claim, collect or run. Worth a check with legal and a plain-English explainer for customers.
STAT
STAT+: Pharma is a ‘mixed bag’ when providing drug access to low- and middle-income countries, analysis finds
A move in your market that customers and prospects will hear about. Worth checking against your positioning before someone asks.
STAT
Why this year’s flu season could be hitting teens and young adults hard
A move in your market that customers and prospects will hear about. Worth checking against your positioning before someone asks.
STAT
STAT+: PepGen says early trial for muscular dystrophy drug looks promising
A move in your market that customers and prospects will hear about. Worth checking against your positioning before someone asks.
STAT
STAT+: State Democratic wins make Medicaid expansion a possibility for more than a million people
A move in your market that customers and prospects will hear about. Worth checking against your positioning before someone asks.
STAT
Opinion: AI’s health advice can be accurate and still make us sicker
Technology your buyers use to find and judge you is changing. Worth knowing before it shows up in their questions.
STAT
Opinion: STAT+: BIO CEO: American biotech needs a coordinated plan to beat China — now
A move in your market that customers and prospects will hear about. Worth checking against your positioning before someone asks.
STAT
London biotech Oyster harvests $60M for tau-targeting brain drugs
A move in your market that customers and prospects will hear about. Worth checking against your positioning before someone asks.
BioPharma Dive
Montana Healthcare Gets Big Boost Thanks to President Trump
A move in your market that customers and prospects will hear about. Worth checking against your positioning before someone asks.
k96fm.com